Information about Jay Therapeutics
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0771.305.101

VAT liability
Yes
Established
12-07-2021
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Jay Therapeutics

2024 2023 2022
Profit/Loss -158,140 80 % -773,904 53 % -1,638,129
Equity 29,827 -84 % 187,967 -80 % 961,871
Gross margin -27,154 72 % -96,302 40 % -160,743

Publications from Jay Therapeutics

Date Publication
30-11-2022 Capital - Shares - Resignations - Appointments (NL)
23-07-2021 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital - Shares (NL)
14-07-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Jay Therapeutics?
The VAT number of Jay Therapeutics is BE 0771.305.101.
Wat is the PEPPOL ID of Jay Therapeutics?
There is no information available about the PEPPOL ID of Jay Therapeutics or the company is not yet registered on the PEPPOL network.
When was Jay Therapeutics founded?
Jay Therapeutics was founded on 12-07-2021.
What is the address of Jay Therapeutics?
The current registered office of Jay Therapeutics is located at Pieter van Reysschootlaan 2/104, 9051 Gent.
When was the last time Jay Therapeutics filed their annual financial statements?
The most recent financial statements of Jay Therapeutics were filed on 04-06-2025.
How many employees does Jay Therapeutics have?
There are currently no employees working at Jay Therapeutics or no workforce information is available.
What is the annual turnover of Jay Therapeutics?
At the time of its most recent financial statements, Jay Therapeutics did not publish any turnover figures. Jay Therapeutics reported a gross margin of -€27,153.83.